REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes.
about
How Can We Realize the Clinical Benefits of Continuous Glucose Monitoring?Clinical Use of Continuous Glucose Monitoring in Adults with Type 1 Diabetes.The Future of Continuous Glucose Monitoring.Clinical Use of Continuous Glucose Monitoring in Adults with Type 2 Diabetes.Commentary Regarding Shapiro, "Nonadjunctive Use of Continuous Glucose Monitors for Insulin Dosing: Is It Safe?"Decreased complexity of glucose dynamics preceding the onset of diabetes in mice and rats.Improving the clinical value and utility of CGM systems: issues and recommendations : A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.Cost-effectiveness of G5 Mobile continuous glucose monitoring device compared to self-monitoring of blood glucose alone for people with type 1 diabetes from the Canadian societal perspective.Blood Glucose Monitoring Data Should Be Reported in Detail When Studies About Efficacy of Continuous Glucose Monitoring Systems Are Published.The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be Misleading.A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System for the Management of Adults With Diabetes.Advances in Glucose Monitoring and Automated Insulin Delivery: Supplement to Endocrine Society Clinical Practice GuidelinesCost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized TrialPractical guidance for treatment of patients with diabetes using flash glucose monitoring: a pilot studyMeasurement Performance of Two Continuous Tissue Glucose Monitoring Systems Intended for Replacement of Blood Glucose Monitoring
P2860
Q33727447-E14CAE42-3571-4D14-97B4-41D373E4EA88Q33727481-55893219-675E-4E26-9BA2-7B51E88F840BQ38674274-A52995EA-336F-432F-B5F6-21940C9436A3Q38679404-EF2AEAE6-2734-4EAE-973A-147EB6E2F063Q38707085-51D4D350-B453-4AD9-9E0F-5FD8300471D9Q41634468-F304F262-1154-4237-962B-CA3587729727Q46007893-E054CB30-BF14-4AD6-B7F8-E890FC7D862FQ47878608-5D865281-B646-4397-97EE-6A3842331C9DQ48263557-863565E1-6E1A-4E0C-AABD-23584960243EQ48364304-BB9EC64A-7F0E-4504-A5EF-78266C001ABEQ52712454-4CD7BBB0-650B-46E1-B446-C504D65CFB48Q57483085-03599F22-AD22-4575-BDE4-2C27E31FCE22Q58566965-A5A0BBB4-0F50-45EB-B873-80E5C275F983Q58797519-12019E92-314B-4A05-9429-E9DA586FE5D8Q58806287-3460C644-45DD-4BA6-99C0-5B4227A1C904
P2860
REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
REPLACE-BG: A Randomized Trial ...... ll-Controlled Type 1 Diabetes.
@en
REPLACE-BG: A Randomized Trial ...... ll-Controlled Type 1 Diabetes.
@nl
type
label
REPLACE-BG: A Randomized Trial ...... ll-Controlled Type 1 Diabetes.
@en
REPLACE-BG: A Randomized Trial ...... ll-Controlled Type 1 Diabetes.
@nl
prefLabel
REPLACE-BG: A Randomized Trial ...... ll-Controlled Type 1 Diabetes.
@en
REPLACE-BG: A Randomized Trial ...... ll-Controlled Type 1 Diabetes.
@nl
P2093
P2860
P921
P356
P1433
P1476
REPLACE-BG: A Randomized Trial ...... ll-Controlled Type 1 Diabetes.
@en
P2093
Andrew J Ahmann
Anne L Peters
Anuj Bhargava
Athena Philis-Tsimikas
Bruce W Bode
Davida F Kruger
Elena Toschi
Emily Eyth
Grazia Aleppo
Henry Rodriguez
P2860
P304
P356
10.2337/DC16-2482
P407
P577
2017-02-16T00:00:00Z